Logo

ACMG: Maximilian Muenke

Sep 03, 2019

Maximilian Muenke has been named CEO of the American College of Medical Genetics and Genomics, succeeding Michael Watson. He will take up his new position on Oct. 7. Since 2000, Muenke has served as senior investigator, head of the human development section, and chief of the medical genetics branch at the National Human Genome Research Institute. Previously, he was a faculty member at the University of Pennsylvania. He holds an MD degree from the Free University of Berlin School of Medicine in Germany.

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.